Indiana Jones and the Dial of Destiny, the highly anticipated fifth installment in the popular adventure film series, has fallen short of expectations in its North American weekend debut, delivering a blow to theaters' hopes of a strong recovery from the pandemic. The film, featuring the iconic globe-trotting archaeologist played by Harrison Ford, brought in $60 million in ticket sales, missing the projected $70.3 million estimate by Box Office Pro.
While the film did perform well outside of North America with $70 million in sales, the disappointing domestic numbers are a cause for concern for its distributor, Walt Disney Co., as well as the movie's producer, Lucasfilm. This setback comes on the heels of two other underperforming movies this summer, Warner Bros.' The Flash and Disney's Elemental, which have led analysts to revise their forecasts for the year and raise doubts about the long-term outlook for theaters.
The pandemic has significantly impacted consumer demand for going to the movies. Bloomberg Intelligence analysts wrote that the demand is currently in flux, with a projected full-year ticket sales estimate of about $8.8 billion in North America, down from the previous estimate of $9.2 billion. Before the pandemic, the annual ticket sales in North America exceeded $11 billion.
Furthermore, the analysts express concerns about the production delays caused by the ongoing strike of writers in Hollywood, which could further delay the full recovery of the theatrical industry beyond the next couple of years.
Although theater revenues have increased by 18% from last year, with domestic ticket sales reaching $4.54 billion, they are still 21% lower than the same period in 2019. The disappointing performance of Indiana Jones and the Dial of Destiny is particularly noteworthy as it is popular among older audiences who have been more reluctant to return to theaters.
Despite the setback, the film received mostly favorable reviews from critics, with about two-thirds recommending it, according to Rotten Tomatoes. However, the film's hefty production budget of approximately $295 million, along with significant marketing expenses, will make it challenging for the movie to break even.
There is still hope for the theatrical industry, as a couple of highly anticipated films are set to release later this month. Mission: Impossible - Dead Reckoning Part One, starring Tom Cruise, is expected to generate over $300 million in North America, while Warner Bros.' Barbie could bring in up to $240 million domestically. Additionally, the Cruise-Paramount collaboration, Top Gun: Maverick, was one of the highest-grossing films of 2022 in the US, with $718.7 million in ticket sales, indicating that there is still potential for successful box office runs in the near future.